BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19631637)

  • 1. VEGF-A and Semaphorin3A: modulators of vascular sympathetic innervation.
    Long JB; Jay SM; Segal SS; Madri JA
    Dev Biol; 2009 Oct; 334(1):119-32. PubMed ID: 19631637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NRP1 and NRP2 cooperate to regulate gangliogenesis, axon guidance and target innervation in the sympathetic nervous system.
    Maden CH; Gomes J; Schwarz Q; Davidson K; Tinker A; Ruhrberg C
    Dev Biol; 2012 Sep; 369(2):277-85. PubMed ID: 22790009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropilin ligands in vascular and neuronal patterning.
    Fantin A; Maden CH; Ruhrberg C
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1228-32. PubMed ID: 19909252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective requirements for NRP1 ligands during neurovascular patterning.
    Vieira JM; Schwarz Q; Ruhrberg C
    Development; 2007 May; 134(10):1833-43. PubMed ID: 17428830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF promotes vascular sympathetic innervation.
    Marko SB; Damon DH
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2646-52. PubMed ID: 18408130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the neuropilin ligands VEGF164 and SEMA3A in neuronal and vascular patterning in the mouse.
    Vieira JM; Schwarz Q; Ruhrberg C
    Novartis Found Symp; 2007; 283():230-5; discussion 235-41. PubMed ID: 18300426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.
    Bouvrée K; Brunet I; Del Toro R; Gordon E; Prahst C; Cristofaro B; Mathivet T; Xu Y; Soueid J; Fortuna V; Miura N; Aigrot MS; Maden CH; Ruhrberg C; Thomas JL; Eichmann A
    Circ Res; 2012 Aug; 111(4):437-45. PubMed ID: 22723296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sema3A maintains corneal avascularity during development by inhibiting Vegf induced angioblast migration.
    McKenna CC; Ojeda AF; Spurlin J; Kwiatkowski S; Lwigale PY
    Dev Biol; 2014 Jul; 391(2):241-50. PubMed ID: 24809797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semaphorin3A regulates axon growth independently of growth cone repulsion via modulation of TrkA signaling.
    Ben-Zvi A; Ben-Gigi L; Yagil Z; Lerman O; Behar O
    Cell Signal; 2008 Mar; 20(3):467-79. PubMed ID: 18096366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurovascular congruence results from a shared patterning mechanism that utilizes Semaphorin3A and Neuropilin-1.
    Bates D; Taylor GI; Minichiello J; Farlie P; Cichowitz A; Watson N; Klagsbrun M; Mamluk R; Newgreen DF
    Dev Biol; 2003 Mar; 255(1):77-98. PubMed ID: 12618135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF-A and neuropilin 1 (NRP1) shape axon projections in the developing CNS via dual roles in neurons and blood vessels.
    Erskine L; François U; Denti L; Joyce A; Tillo M; Bruce F; Vargesson N; Ruhrberg C
    Development; 2017 Jul; 144(13):2504-2516. PubMed ID: 28676569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas.
    Barresi V; Tuccari G
    Neuropathology; 2010 Oct; 30(5):537-46. PubMed ID: 20337947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semaphorin 3A is a retrograde cell death signal in developing sympathetic neurons.
    Wehner AB; Abdesselem H; Dickendesher TL; Imai F; Yoshida Y; Giger RJ; Pierchala BA
    Development; 2016 May; 143(9):1560-70. PubMed ID: 27143756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-30b promotes axon outgrowth of retinal ganglion cells by inhibiting Semaphorin3A expression.
    Han F; Huo Y; Huang CJ; Chen CL; Ye J
    Brain Res; 2015 Jun; 1611():65-73. PubMed ID: 25791621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current advances in research of semaphorin 3A:a potential target for the treatment of nospecific low back pain].
    Xin L; Xu WX; Wang J; Song HP; Liu J; Wang J; Fan SW; Yang Y
    Zhongguo Gu Shang; 2021 Jun; 34(6):589-92. PubMed ID: 34180183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semaphorin 3A receptor inhibitor as a novel therapeutic to promote innervation of bioengineered teeth.
    Kuchler-Bopp S; Bagnard D; Van-Der-Heyden M; Idoux-Gillet Y; Strub M; Gegout H; Lesot H; Benkirane-Jessel N; Keller L
    J Tissue Eng Regen Med; 2018 Apr; 12(4):e2151-e2161. PubMed ID: 29430872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-immobilization of semaphorin3A and nerve growth factor to guide and pattern axons.
    McCormick AM; Jarmusik NA; Leipzig ND
    Acta Biomater; 2015 Dec; 28():33-44. PubMed ID: 26391495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cell-derived semaphorin 3A inhibits filopodia formation by blood vascular tip cells.
    Ochsenbein AM; Karaman S; Proulx ST; Berchtold M; Jurisic G; Stoeckli ET; Detmar M
    Development; 2016 Feb; 143(4):589-94. PubMed ID: 26884395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropilin-1 receptor in the rapid and selective estrogen-induced neurovascular remodeling of rat uterus.
    Richeri A; Vierci G; Martínez GF; Latorre MP; Chalar C; Brauer MM
    Cell Tissue Res; 2020 Aug; 381(2):299-308. PubMed ID: 32242249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.